RxDoctor Payments Data

K Dean Arnaoutakis, MD

Vascular Surgery · Tampa, FLNPI 1699099507

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (26.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Bolton Medical Inc at 46.7% of the total. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$114,951in general payments, 2019–2025

Across 244 payments — averaging $471.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bolton Medical Inc$54K
  • W. L. Gore & Associates, Inc.$23K
  • Cook Incorporated$21K
  • Medtronic$11K
  • Cook Medical LLC$3K
  • Penumbra, Inc.$2K
  • plus $900 from 5 others
$157,496in research payments, 2019–2025

Across 29 payments — averaging $5430.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$103K
  • W. L. Gore & Associates, Inc.$45K
  • Shape Memory Medical Inc.$8K
  • Cook Research Incorporated$2K

What the payments were for

  • Consulting fees$30,27026%
  • Speaking & faculty fees$29,90526%
  • Grants$10,0629%
  • Travel & lodging$29,75626%
  • Food & beverage$10,5329%
  • Education$4,4264%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$114,951 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$188,601
Medicare patients
319
Services billed
713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$27,222
XareltoRivaroxaban25$21,937
BrilintaTicagrelor25$12,722
ClopidogrelClopidogrel Bisulfate94$1,163
Cilostazol50$937
Rosuvastatin Calcium11$42

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →